Author

Jane Møller Hansen 1

1 Odense University Hospital,Dept. of Gastroenterology,Odense,Denmark

CAN THE USE OF A COMPUTER DECISION SUPPORT SYSTEM PREVENT COMPLICATED ULCER AMONG PATIENTS TREATED WITH NSAID OR ASPIRIN? A RANDOMISED CONTROLLED CLUSTER TRIAL IN GENERAL PRACTICE.

Johanna Martina Petersen, Dorte Ejg Jarbøl, Jesper Hallas, Maria Reumert Munch, Ove B. Schaffalitzky de Muckadell, Jane Møller Hansen

COST EFFECTIVENESS OF HELICOBACTER PYLORI POPULATION SCREENING: ECONOMIC EVALUATION ALONGSIDE A RANDOMIZED CONTROLLED TRAIL WITH 13-YEARS FOLLOW-UP (THE HEP-FYN STUDY)

Maria Bomme Høgh, Christian Kronborg, Jane Møller Hansen, Mette Wildner-Christensen, Jesper Hallas, Ove B. Schaffalitzky de Muckadell

DISCONTINUATION OF INFLIXIMAB THERAPY IN PATIENTS WITH CROHN’S DISEASE IN SUSTAINED, COMBINED CLINICAL-BIOCHEMICAL-ENDOSCOPIC REMISSION: A DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL

Sine Buhl, Casper Steenholdt, Jens Frederik Dahlerup, Tobias Wirenfeldt Klausen, Mark Andrew Ainsworth, Jørgen Jahnsen, Jørn Brynskov, Ole Østergaard Thomsen, Katrine Risager Christensen, Akbar Molazahi, Natalia Pedersen, Niels Thorsgaard, Eva Efsen Dahl, Ida Vind, Hendrika Adriana Linda Kievit, Taina Sipponen, Jan Marsal;;

EFFECTS OF COMMUNITY SCREENING FOR HELICOBACTER PYLORI: 13-YEAR FOLLOW-UP OF A RANDOMIZED CONTROLLED TRIAL (HEP-FYN)

Maria Bomme, Jane Møller Hansen, Mette Wildner-Christensen, Jesper Hallas, Ove Schaffalitzky de Muckadell

EFFECTS OF HELICOBACTER PYLORI STATUS ON DYSPEPSIA, PEPTIC ULCER, HEALTH CARE USE OR QUALITY OF LIFE - HEP-FYN 13-YEAR FOLLOW-UP

Maria Bomme, Jane Møller Hansen, Mette Wildner-Christensen, Jesper Hallas, Ove B. Schaffalitzky de Muckadell

Test for H. pylori first

Peter Malfertheiner, Jane Møller Hansen

Item 1 - 6 / 6
1